Desmoplastic reaction in the microenvironment of head and neck and other solid tumors: the therapeutic barrier

Kohei Okuyama1, Maiko Tsuchiya2, Kala Chand Debnath3

  • 1Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 123, Houston, TX 77030-4009, USA.

Insights

The desmoplastic reaction (DR) in head and neck squamous cell carcinoma (HNSCC) promotes cancer progression and treatment resistance. Targeting DR and its associated stromal components offers promising therapeutic strategies for HNSCC.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment Research

Background:

  • Head and neck squamous cell carcinoma (HNSCC) presents significant challenges due to a lack of effective prognostic biomarkers and therapies.
  • The tumor microenvironment (TME), specifically the desmoplastic reaction (DR) involving stromal fibrosis, is increasingly recognized for its role in HNSCC progression and therapeutic resistance.

Purpose of the Study:

  • To review the biological significance of the desmoplastic reaction (DR) in the initiation, progression, and treatment resistance of HNSCC.
  • To explore the impact of DR on clinical outcomes, immune responses, and therapeutic strategies in HNSCC.

Main Methods:

  • Literature review synthesizing existing research on the desmoplastic reaction in HNSCC.
  • Analysis of histological correlations between DR, invasion patterns, and patient survival.
  • Examination of the role of cancer-associated fibroblasts (CAFs) and extracellular matrix remodeling in DR-mediated effects.

Main Results:

  • DR in HNSCC is linked to specific invasion patterns and negatively impacts disease-free and overall survival.
  • CAFs within the TME contribute to immune evasion and resistance to immunotherapy.
  • DR influences epithelial-mesenchymal transition, bone invasion, and chemotherapy resistance via CAF signaling pathways.

Conclusions:

  • The desmoplastic reaction is a critical factor in HNSCC progression and resistance to various therapies, including immunotherapy.
  • Distinct DR characteristics in human papillomavirus-driven HNSCC influence prognosis.
  • Targeting DR and stromal interactions presents a viable strategy to enhance therapeutic efficacy in HNSCC.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K